Sanofi sees vaccine trial completed in first quarter

(56)

Sanofi – See Hemophilia Through My Eyes: Women \u0026 Girls

(3:22)

Sanofi – Seeing the Person, Not Just the Patient

(2:48)

Recordati CEO sees 'substantial opportunity' in Sanofi drug purchase

(3:47)

Sanofi – See Hemophilia Through My Eyes: Communication

(3:10)

Sanofi – See Hemophilia Through My Eyes: Mental Health

(3:13)

Sanofi – See Hemophilia Through My Eyes: Careers

(3:37)

How SandboxAQ and Sanofi are transforming healthcare with AI | CNBC International

(2:10)

Sanofi – Rare. We Are Many.

(1:37)

Selling Fear to Sell Medicines: The Juicy Health Market - World Documentary - DNA

(52:1econd)

What's the 'New Sanofi' Like? Let CEO Paul Hudson Explain. | At Barron's

(19:37)

Special Interview | Sanofi to Become No 1 in Healthcare in KSA by End of 2024 CEO: Paul Hudson

(9:20)

Sanofi CEO Paul Hudson on Q3 results: The modernization effort is starting to pay off

(6:27)

Sanofi CEO Paul Hudson: We have one of the best growth profiles in all of Big Pharma

(4:24)

Sanofi’s CEO on How Company Culture Can Thrive in a Distributed, Hybrid World

(32:36)

Sanofi Singapore's New Office

(3:26)

Sanofi – Understanding the Impact of Bias in Women’s Healthcare

(3:54)

Sanofi CEO Paul Hudson on Q1 results: Hope to gather even more momentum later this year

(3:1econd)

Interview for Sanofi Pharmaceutical

(4:19)

Sanofi CEO Paul Hudson: We've got perhaps the world's best immunology pipeline

(5:)

Sanofi – Consumer Healthcare – Our Colleagues, Our Mission

(2:27)

Sanofi CEO on AI's Impact, Lung Disease Drug Clearance

(8:54)

Sanofi and GSK see positive interim results for their Covid vaccine in trials

(2:31)

Sanofi Soundbites: Meet Marie Debans

(1:)

Sanofi – Perspective - Tech care of yourself

(15:52)

Sanofi – Rohini Anand on Diversity, Equity and Inclusion

(3:25)

Sanofi – Meet the Unmet: Meet Sandra and Lindsey

(1:20)

Sanofi - Meet Jessie: Behind the Science

(2:40)

Sanofi - Introducing Sanofi’s Global Health Unit

(1:51)

Sanofi: The arrival of the ‘haute couture’ supply chain

(1:34)